Investigation Announcement: The investigation seeks to determine whether the proposed $22.00 per share provides sufficient consideration for the Company's shareholders, and whether the Company's ...
Transaction Details: Ensysce Biosciences, Inc. will become a public company traded on the NASDAQ. The public stockholders of Leisure Acquisition will own 15.5% of the post-close Ensysce. Transaction ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback